While recurrence in hepatitis features was not observed, trial of pravastatin cannot be considered a true rechallenge, as structural differences between the statins may have accounted for the lack of recurrence
While some preclinical research has explored potential immunomodulatory effects of GLP-1 receptor agonists, there is currently insufficient clinical evidence to establish this as a mechanism for systemic symptoms in patients taking tirzepatide
Set aside time to sit on the toilet, even if you do not feel an urgent need to go
Matsuzawa D, Obata T, Shirayama Y, Nonaka H, Kanazawa Y, Yoshitome E, et al
Given the critical importance of stability and bioavailability for peptide research utility, we strongly recommend using BPC 157 in its optimal lyophilised form for research purposes